Carlyle Group Inc. Spruce Biosciences, Inc. Transaction History
Carlyle Group Inc.
- $80.7 Million
- Q2 2025
Shares
1 transactions
Others Institutions Holding SPRB
# of Institutions
7Shares Held
6.9MCall Options Held
0Put Options Held
0-
River Vest Venture Management LLC St. Louis, MO2.94MShares$26.9 Million20.39% of portfolio
-
Abingworth LLP London, X01.79MShares$16.4 Million0.65% of portfolio
-
Acadian Asset Management LLC Boston, MA1.05MShares$9.57 Million0.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX1MShares$9.15 Million0.02% of portfolio
-
Black Rock Inc. New York, NY125KShares$1.14 Million0.0% of portfolio
About SPRUCE BIOSCIENCES, INC.
- Ticker SPRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,560,200
- Market Cap $216M
- Description
- Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...